Aptevo Therapeutics Inc. — Director's Dealing 2018

Mar 14, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aptevo Therapeutics Inc. (APVO)
CIK: 0001671584
Period of Report: 2018-03-09

Reporting Person: Gross Jane A (See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-09	Common Stock	M	9728	—	Acquired	105437	Direct
2018-03-09	Common Stock	F	2282	$3.13	Disposed	103155	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-09	Employee Stock Options (Right to Buy)	$3.13	A	67400	Acquired	2028-03-09	Common Stock (67400)	Direct
2018-03-09	Restricted Stock Unit	$	M	9728	Disposed		Common Stock (9728)	Direct

Footnotes

F1: Each RSU converts into the Issuer's common stock on a one-for-one basis.

F2: On March 9, 2018, the reporting person was granted 67,400 stock options vesting in three equal annual installments beginning on the first anniversary of the grant date.

F3: The RSUs were originally issued by Emergent BioSolutions, Inc. ("Emergent") on March 10, 2015. As a result of the spin-off of the Issuer from Emergent effective on August 1, 2016, each RSU was adjusted and assumed by the Issuer. The RSUs fully vested as of March 9, 2018.